Beyond the AI Trade: 3 Defensive Stocks Built for Stability Safe haven stocks can help reduce portfolio volatility because their buy-and-hold investors are less likely to see on bad news than buy. MarketBeat · Jun 20
3 Dividend Increases Investors Can Actually Trust UnitedHealth, Caterpillar, and Donaldson raised quarterly dividends by 5%, 8%, and 6.7%, respectively, with earnings coverage indicating sustainable payouts for all three companies. MarketBeat · Jun 15
UnitedHealth Stock Jumps on Upgrade From Bank of America. UNH Is No Longer Just an Insurance Company. The reputed broker cited the company's strong Q1 results for the upgrade. Barchart · Jun 5
UnitedHealth Just Raised Its Dividend 5%. Why You Should Buy UNH Stock Here. UnitedHealth Group raised its quarterly dividend by 5% to $2.32 per share, marking its 16th consecutive year of dividend increases amid a challenging health insurance environment with rising medical costs. Barchart · Jun 4
Bank of America Just Upgraded UnitedHealth Stock. Here's Why. UnitedHealth stock rallies as Bank of America upgrades it to “Buy.” Here’s why analyst Kevin Fischbeck believes UNH shares could rip higher from here. Barchart · Jun 4
Broadcom Can't Cap Dow's 874-Point Bounce: Stock Market Today Technology was one of only two sectors not to close higher on Thursday, and it was basically all about one semiconductor stock. Kiplinger · Jun 4
Wall Street Turns Bullish on Health Insurers: UNH Surges 5.7% as BofA Upgrades and Morgan Stanley Raises Target to $453 UnitedHealth Group was written off by many investors after five straight sessions of losses. Then Thursday morning arrived — with two simultaneous Wall Street upgrades, easing medical cost data, and a technical setup that had been coiling for a breakout. Here is what changed, what it means for patients, and… Medical Daily · Jun 4
Greg Abel Sells Berkshire Hathaway Stake in UnitedHealth Triggering Stock Slide. Bet on UNH Here for a Turnaround. Berkshire Hathaway dumped its UnitedHealth stake, sending UNH stock lower. But the real story for long-term investors is far more encouraging. Barchart · May 20
UnitedHealth falls after Berkshire sells stake in health insurer UnitedHealth stock is up about 20% so far this year, after falling more than 30% last year, which had made it the worst performer on the Dow Jones Industrial Average index in 2025. The Economic Times · May 18
Are Wall Street Analysts Predicting UnitedHealth Stock Will Climb or Sink? UnitedHealth has substantially underperformed the broader market over the past year amid regulatory and operational challenges, although analysts continue to maintain a cautiously constructive view on the company’s long-term growth prospects. Barchart · May 13
UnitedHealthcare Fires Staffer After Viral 'Aww They Missed' Remark Regarding The Donald Trump Assassination Attempt UnitedHealthcare fired a social media manager after she expressed sympathy for an assassination attempt on President Trump, highlighting the company's zero-tolerance policy on violence. International Business Times UK · Apr 28
UnitedHealth Is Back! But Should You 'Long-Term Care' About UNH Stock? UnitedHealth reported Q1 earnings earlier this week, and it's a comeback story worth watching. Here's what to know. Barchart · Apr 23
UnitedHealth Just Raised Its Full-Year Guidance. Is the Long-Anticipated Turnaround in UNH Stock Finally Here? UnitedHealth’s blowout Q1 marks the first clear, numbers‑backed step toward a real turnaround after last year’s credibility hit. Barchart · Apr 23
Trump team delays pilot program for Medicare to cover cost of ‘fat shot’ Without insurance or discounts, GLP-1 injectables can cost more than $1,000 per month The Independent UK · Apr 22
Barchart · Apr 21 UnitedHealth Stock Just Surged Into Overbought Territory. Is It Too Late to Bet on a Turnaround? UnitedHealth shares rally on strong Q1 earnings and impressive full-year guidance. Here’s why it isn’t too late to invest in UNH stock yet.
MarketBeat · Apr 21 A Healthy Rebound Could Lie Ahead for UNH Shareholders UnitedHealth Group is in the midst of a reversal that could lead to a significant stock price advance over time. Valuation suggests 400% isn't beyond hope.
Barchart · Apr 9 Dear UnitedHealth Stock Fans, Mark Your Calendars for April 21 UNH stock is facing very tough challenges as the company gears up to report first-quarter earnings.
Barchart · Apr 7 If You Are Buying Into the Comeback Story in UnitedHealth Stock, Buy This ETF Too As UNH shares pop higher, consider the iShares U.S. Healthcare Providers ETF too.
Barchart · Apr 7 UnitedHealth Stock Is Poised to Break Through 100-Day Moving Average on CMS 2027 Rate Updates. Should You Buy UNH Here? UnitedHealth stock soars as CMS finalizes 2027 reimbursement rates for Medicare Advantage plans at 2.48%. Bernstein explains why UNH shares are worth buying at current levels.
Barchart · Apr 2 UnitedHealth Stock Is Down Nearly 50% over the Past Year, but This 1 Analyst Is Still Betting on UNH to Outperform Beaten-down UnitedHealth stock has received an “Outperform” rating from Raymond James analysts.
Barchart · Mar 23 UnitedHealth Stock Is Down 18% in 2026 and Keeps Stumbling. Should You Buy the Dip Monday? UnitedHealth stock sinks on widening gap between reimbursement rates and medical expenses. Here’s why UNH shares are still worth owning in 2026.
The Independent UK · Mar 19 New York man pleads guilty to cyberstalking in threats to relative of the late UnitedHealthcare CEO An upstate New York man pleaded guilty to cyberstalking and admitted to leaving threatening voicemails for a family member of slain UnitedHealthcare CEO Brian Thompson
Fortune · Feb 11 TrumpRx is here and it helps, though a bit less than advertised Trump's Republican Party continues to shift toward government market interventionism.
Barchart · Jan 30 Why Piper Sandler Thinks UnitedHealth Stock Is the Top Insurer to Buy Now UNH stock is facing significant risk due to the Trump administration's focus on the health insurance sector.
Barchart · Jan 28 Down 46% Over the Past Year, Should You Sell UnitedHealth Stock? UNH’s slump ties to Medicare uncertainty and restructuring costs, leaving investors weighing near-term pain against historically cheap valuation.